Conference catch-up: The rise of digital therapeutics (part 1)
Healthcare technologies are revolutionizing the ways in which life sciences organizations develop and deliver life-saving treatments to patients. In particular, digital therapeutics have become a prominent area of focus due to their potential to improve outcomes while reducing patient burden. Norstella continues to be proponent for these innovative technologies, partnering with organizations to launch their […]
Redefining patient access strategy
Patient access continues to be a major hurdle in the US pharma industry, impacting the speed of drug development and therefore the delivery of life-saving treatments to patients. To assess the current state of patient access, Norstella’s Managed Markets Insight & Technology (MMIT) surveyed over 300 industry professionals on major trends and challenges in pharma […]
The next wave in oncology: 7 innovations redefining cancer treatment in 2024 and beyond
Oncology is undergoing a transformative shift, with new therapies and technologies driving significant improvements in cancer care. The Next Wave in Oncology explores seven groundbreaking advancements, from antibody-drug conjugates (ADCs) to artificial intelligence, that are redefining how cancer is treated. Staying up to date on these innovations is essential for those navigating the rapidly changing […]
How Norstella is embedding artificial intelligence to improve pipeline to patient decision-making
In this white paper, Norstella describes its vision for the integration of artificial intelligence with its industry-leading data and advisory services. At each step from pipeline to patient, Norstella is embedding AI to create the next generation of solutions. These will help biopharma professionals to better contextualize their challenges, predict how scenarios will play out, […]
Class of 2024: Norstella intern yearbook
As members of a vastly expanding industry, it is our job to empower other problem-solvers and pioneers who will one day become key change-drivers leading the way to a brighter future. Norstella has always been committed to championing new ideas that come from diverse pools of talent, which is why we are thrilled to host our […]
Putting the patient first: Advancing biopharma innovation and industry transformation
Norstella is driven by its mission: Helping patients gain access to life-saving therapies by transforming the drug development journey. Norstella is working to fulfill this mission in a challenging landscape for pharmaceutical, medtech, and clinical research organizations. With this as the context, Norstella recently held a recent roundtable discussion in London featuring several members of […]
Obesity R&D in 2024 & beyond: Key considerations in an increasingly competitive landscape
Norstella empowers stakeholders involved in obesity drug development to make informed decisions based on trusted industry data and expert insights. This infographic uses some of those data and insights to demonstrate the various complex factors that continue to impact obesity R&D, assess expectations for future development in this space, and emphasize how Norstella serves as […]
Unlocking success in the evolving pharma landscape: Insights from Norstella’s Daniel Chancellor
Recent breakthroughs in obesity, Alzheimer’s, and other major disease areas are reshaping pharma R&D priorities and forcing companies to rethink pipeline strategy, payer value communication, and long-term growth. The discussion highlights the importance of learning from both drug development successes and failures, while emphasizing emerging opportunities in areas like cell, gene, and RNA therapies, as […]
Paving the way for women in life sciences
The ultimate success of the life sciences industry is highly dependent on a diverse workforce of pioneers, collaborators, and change-drivers, though there is still progress to be made with regard to gender equality in this field. Life sciences organizations are thus exploring ways to best prioritize diversity, including how to advocate for equality among leadership […]
How real-world evidence is impacting regulatory decision-making: A collection of 10 recent regulatory decisions based on RWE
Volume 3 Discover the power of real-world evidence (RWE) in shaping regulatory decisions through “How RWE is Impacting Regulatory Decision-Making.” Volume 3 of Panalgo’s popular use cases series reveals 10 recent instances where life sciences companies have not only invested in RWE but have successfully utilized it in their submissions to the FDA and other […]